Cerulean Pharma reported $-8400450 in Operating Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Agile Therapeutics AGRX:US -15573000 6.78M
Arrowhead Research ARWR:US $ 41.55M 104.87M
Bayer BAYN:GR 4.21B 2.19B
Biocept BIOC:US $ -2.71M 0.07M
Brainstorm Cell Therapeutics BCLI:US $ -5475000 737K
Cerulean Pharma CERU:US $ -8400450 1.14M
Immunogen IMGN:US $ -22.85M 11.7M
Johnson & Johnson JNJ:US $ 5862M 1026M
Macrogenics MGNX:US $ -66638000 8.4M
Merk MRK:US $ 5569M 1994M
Nektar Therapeutics NKTR:US $ -116.56M 3.65M
Perrigo Ordinary Shares PRGO:US $ 21.7M 25M
Pfizer PFE:US $ 9873M 5297M
Seattle Genetics SGEN:US $ -133.05M 39.02M
YTE INCY:US $ 116.54M 5.81M